Related Experiment Video

Updated: Jun 2, 2026

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
08:36

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

Progress in anti-invasion and anti-metastasis research and treatment

W Jiang, R Mansel

    International Journal of Oncology
    |May 5, 2011
    PubMed

    Insights

    Cancer metastasis, the spread of cancer cells to distant sites, is a major threat. Recent advances have improved our understanding of tumor invasion and metastasis mechanisms, leading to new treatment strategies.

    Area of Science:

    • Oncology
    • Cancer Biology
    • Molecular Medicine

    Background:

    • Distant metastasis is the primary cause of cancer-related mortality.
    • Significant progress has been made in understanding the molecular and cellular basis of tumor invasion and metastasis over the past decade.

    Purpose of the Study:

    • To summarize recent advancements in research and treatment strategies targeting cancer invasion and metastasis.
    • To highlight the potential of novel anti-invasion and anti-metastasis agents.

    Main Methods:

    • Review of current scientific literature on tumor invasion and metastasis.
    • Analysis of emerging therapeutic strategies and agents.
    • Synthesis of knowledge on molecular and cellular mechanisms.

    Main Results:

    • Increased understanding of the complex processes driving cancer spread.
    • Identification of several agents showing promise in preclinical or early clinical studies.
    • Development of potential anti-invasion and anti-metastasis therapies.

    Conclusions:

    • Continued research into the mechanisms of metastasis is crucial for developing effective treatments.
    • Targeting tumor invasion and metastasis offers a promising avenue for improving patient outcomes.
    • Novel therapeutic strategies are emerging to combat the life-threatening consequences of cancer metastasis.

    More Related Videos

    CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

    CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

    Published on: June 2, 2022

    Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay07:44

    Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

    Published on: March 12, 2018

    Related Concept Videos

    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...